Treatment Options for Phantom Pain

Pharmacological Treatment Options

The American Geriatrics Society recommends first-line treatments for phantom pain, including anticonvulsants, tricyclic antidepressants, or serotonin-norepinephrine reuptake inhibitors, with topical agents as adjuncts for localized pain 1, 2, 3
The American College of Physicians suggests that gabapentin can be effective for phantom limb pain, with demonstrated superiority to placebo in clinical trials, starting at 100-300 mg daily and gradually increasing to 900-3600 mg/day in divided doses 1, 3
Pregabalin is FDA approved for neuropathic pain conditions with a similar mechanism to phantom pain, starting at 25-50 mg/day in older adults and gradually increasing to 150-600 mg/day in divided doses 2
Secondary amine tricyclic antidepressants, such as nortriptyline or desipramine, are preferred over tertiary amines due to fewer anticholinergic side effects, starting at low doses and titrating slowly 1, 3
Serotonin-norepinephrine reuptake inhibitors, such as duloxetine or venlafaxine, can be used at doses of 60 mg once daily or 150-225 mg/day, respectively 1, 2
Topical lidocaine 5% patches can be applied to painful areas for up to 12 hours daily, with minimal systemic absorption 2, 5
Capsaicin is available in various concentrations and may cause an initial burning sensation 6

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive option, although evidence is inconclusive 6
Interventional procedures, such as nerve blocks, spinal cord stimulation, or dorsal column stimulation, can be considered for refractory pain 6, 7

Medication selection should consider comorbidities, such as using serotonin-norepinephrine reuptake inhibitors for patients with concurrent depression 1, 3
Elderly patients should start at lower doses and titrate more slowly to minimize adverse effects 2
Regular reassessment of pain, function, and side effects is essential, with an adequate trial of tricyclic antidepressants taking 6-8 weeks 3

Inadequate dosing can lead to treatment failures, and premature discontinuation should be avoided before reaching therapeutic levels 1, 3
Overlooking non-pharmacological approaches can limit comprehensive pain management, and consideration of physical and psychological interventions is necessary 6
Excessive reliance on opioids can carry significant risks of dependency and adverse effects, and should be used judiciously 7